Renovaro Inc. Files 8-K: Material Agreement & Equity Sales
Ticker: LNAI · Form: 8-K · Filed: Feb 28, 2025 · CIK: 1527728
| Field | Detail |
|---|---|
| Company | Renovaro Inc. (LNAI) |
| Form Type | 8-K |
| Filed Date | Feb 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, disclosure
TL;DR
Renovaro Inc. (RNO) filed an 8-K on Feb 26, 2025, reporting a material agreement and equity sales.
AI Summary
Renovaro Inc. entered into a Material Definitive Agreement on February 26, 2025. The company also disclosed unregistered sales of equity securities and provided a Regulation FD disclosure. The filing includes financial statements and exhibits, with the report dated February 28, 2025.
Why It Matters
This 8-K filing indicates significant corporate activity for Renovaro Inc., including a new material agreement and equity transactions, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing involves unregistered sales of equity securities, which can sometimes indicate financial distress or dilution for existing shareholders.
Key Players & Entities
- RENOVARO INC. (company) — Registrant
- February 26, 2025 (date) — Date of earliest event reported
- February 28, 2025 (date) — Date of report
- 001-38758 (company) — SEC File Number
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the nature of the Material Definitive Agreement entered into by Renovaro Inc.?
The filing does not specify the details of the Material Definitive Agreement, only that one was entered into on February 26, 2025.
What type of equity securities were sold in the unregistered sale?
The filing mentions unregistered sales of equity securities but does not provide specific details about the type or amount of securities sold.
What is the purpose of the Regulation FD Disclosure?
The filing indicates a Regulation FD Disclosure was made, but the specific content of this disclosure is not detailed in the provided text.
When was Renovaro Inc. previously known as Enochian Biosciences Inc.?
Renovaro Inc. was formerly known as Enochian Biosciences Inc. after a name change on August 4, 2023.
What is Renovaro Inc.'s Standard Industrial Classification code?
Renovaro Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 28, 2025 regarding RENOVARO INC. (LNAI).